Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
B
Details...
Enter Symbol
Valeant Pharmaceuticals International (NYSE: VRX)
Sector: Medical
Current Price :
$48.04
52 Week Low
$33.85
52 Week High
$56.73
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
306M
Market Cap:
$15.99B
Avg Volume:
1997235
P/E Ratio:
15.610
PEG Ratio:
0.630
Split:
On 10/16/2000 vrx split by factor of 2.000
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
Watson Pharma (WPI) Confirms Patent Challenge For Diabetes Drug Glumetza
Apr 19, 2012 10:57 AM |
DEPO
,
VRX
,
WPI
Negative Reversal Day
Feb 29, 2012 08:09 PM |
AAPL
,
CPRT
,
CSTR
,
EXLS
,
GS
,
IBM
Valeant Pharmaceuticals Retain Buy Rating At Deutsche Bank
Dec 21, 2011 04:42 PM |
VRX
U.S. Stocks End Mixed Amid Europe Worries; Zynga Inc. (NASDAQ:ZNGA) In Focus
Dec 16, 2011 04:22 PM |
CSX
,
FDX
,
FRO
,
ISTA
,
LCC
,
RIMM
U.S. Stocks Mixed In Mid-Day Trade As Euro Worries Resurface
Dec 16, 2011 01:11 PM |
AMGN
,
ISTA
,
RIMM
,
URI
,
VRX
More Articles on VRX..
Market News
Valeant Pharmaceuticals Reports 2011 Third Quarter Financial Results
Nov 03, 2011 09:43 AM |
VRX
Valeant Pharmaceuticals Reports 2011 Second Quarter Financial Results
Aug 04, 2011 09:44 AM |
CEPH
,
VRX
J5 Acquisition Corp. / Trimel Biopharma Holdings Inc. Provide Update on Proposed Qualifying Transaction
Mar 02, 2011 07:54 PM |
VRX
Chicago Tribune Gail MarksJarvis column
Jan 12, 2011 03:58 AM |
BG
,
ING
,
TJX
,
VRX
Daily Mail, London, market report column
Aug 13, 2010 05:52 PM |
AB
,
GSK
,
MS
,
NT
,
SSL
,
SU
More News on VRX..
Press Releases
Critical Alerts For Corning, Expedia, Agnico Eagle Mines, Brinker International, and Valeant Pharmaceutical Released By InvestorsObserver
May 24, 2012 09:31 AM |
AEM
,
EAT
,
EXPE
,
GLW
,
VRX
Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Swiss Herbal
May 24, 2012 07:58 AM |
VRX
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
May 03, 2012 08:11 AM |
VRX
More Press Releases on VRX..
SEC Filings
Form 4 Valeant Pharmaceuticals For: May 17 Filed by: ValueAct Capital Management, L.P. (10K)
May 21, 2012 08:31 PM
Form 4 Valeant Pharmaceuticals For: May 18 Filed by: PAUL LAURENCE E (10K)
May 21, 2012 05:17 PM
Form 4 Valeant Pharmaceuticals For: May 17 Filed by: Farmer Ronald Harold (10K)
May 21, 2012 05:06 PM
More SEC Filings on VRX..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
VRX
Compare to S&P
YTD
11.67 %
0.20 %
4 Weeks
-3.34 %
-2.45 %
12 Weeks
7.62 %
6.22 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
26.67 %
EPS Growth in Last Year:
132.65 %
Sales Growth in Last Quarter:
24.35 %
Sales Growth in Last Quarter:
51.52 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##